DCOYDecoy Therapeutics Inc. · Nasdaq Capital Market · $1.98M mkt cap
Assessed Nov 15, 2026 · Reassessment
Is the float you're seeing correct?
2.28M
Actual float

Outstanding shares, minus insider common and RSAs from the Form 4s and DEF 14A, minus non-insider unvested RSAs.

Confirmed · within 1%
2.28M
Reported float

Data-service feed, fetched today. The number TradingView and most screeners show.

Your screener's float is right for DCOY. Trade off 2.28M shares. What it does not show you is what is about to be added to it.

Dilution risk5/10ELEVATED
CONFIDENCE: HIGH

The float your screener shows is right, at 2.28M. 1 convertible note and 5 reverse splits can add another 251% of the float.

  • Warrant overhang / repricing risk. Armistice holds 4,145,519 warrants at $3.25 (2,368,868 exercisable now plus 1,776,651 milestone warrants), equal to 182% of float and 174% of shares outstanding.

  • Rapid share count growth. Shares outstanding went from 655,185 (8/11/26) to 2,385,282 (11/11/26), up 264% in one quarter, and are up 388% from 488,515 split-adjusted in Nov 2025.

  • Reverse split history. Five reverse splits since 2019 (1:25, 1:25, 1:8, 1:15, 1:12) add up to 900,000:1.

From today's float to the ceiling

shares
2.28M
Actual float
tradeable today
+0 can sell now
2.28M
Effective supply
float plus what sells on notice
+5.82M if floors are cut and warrants exercise
8.10M
Fully diluted
ceiling

Where the shares come from

each subtotal is a rung on the ladder above

Tradeable today
2.28M
Can sell now
Warrants in the money
Exercisable at or below the current tape.
+910.9K
Effective supply
2.28M
Converts only if floors are cut
Notes with no conversion price set
Sized in dollars until a price or floor is set; not counted in the ceiling.
$139.8K
Preferred stock, as converted
Common equivalent at the stated conversion ratio.
+390.6K
Above the current price
Warrants out of the money
Struck above the current tape; supply only if the stock rises.
+4.38M
Options and RSUs
Employee equity; vests and settles over time.
+28.7K
Other, per engine ceiling
Included in the engine's fully-diluted count but not itemised in the filings we parsed.
+1.02M
Fully diluted
8.10M

Not counted anywhere: ATM and shelf capacity. Convertible share counts use stated conversion prices.

Effective supply taken from the engine; it differs from the itemised rows by more than 15%.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue

The facts

Price
—
Market cap
$1.98M
Shares outstanding
2.39M
Reported float
2.28M
Avg volume
47.3K
Reverse splits
5 · latest 1-for-12 · Mar 6, 2026
Going concern
Yes · 2.1 quarters runway
Quarterly burn
$2.71M

Market data as of Nov 22, 2026

Key dates

  • Nov 30, 2026 · Legacy founder notes ($139,823) mature; cash repayment, not convertible
  • Dec 23, 2026 · 180-day ATM/ELOC bar from the June 2026 SPA expires
  • Dec 29, 2026 · Curvature/Ladenburg agent warrants (213,198 at $7.3875) become exercisable
  • Mar 31, 2027 · Nasdaq Mandatory Panel Monitor ends; bid-price failures could prompt a sixth reverse split

New to these numbers?

The full free course